Show simple item record

dc.contributor.authorBartu, Anne
dc.contributor.authorFreeman, N.
dc.contributor.authorGawthorne, G.
dc.contributor.authorAllsop, Steve
dc.contributor.authorQuigley, A.
dc.date.accessioned2017-01-30T12:19:51Z
dc.date.available2017-01-30T12:19:51Z
dc.date.created2009-03-05T00:56:00Z
dc.date.issued2002
dc.identifier.citationBartu, Anne and Freeman, Nerelie and Gawthorne, Geoff and Allsop, Steven and Quigley, Allan . 2002. Characteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone. Drug and Alcohol Review. 21 (4): pp. 335-340.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/20544
dc.identifier.doi10.1080/0959523021000023180
dc.description.abstract

The aims of this study were to examine the retention rates of opiod-dependent clients treate with oral naltrexone and identify factors that influence retention in treatement of 981 opioid-dependent clients at a public out-patient clinic in Perth, Western Australia. The average retention period for all clients was 9.0 weeks. The factors associated with longer retention were being employed and referral source. Clients who were employed stayed significantly longer in treatment than unemployed clients. Clients referred from a pricate clinic were retained in treatment significantly longer than those referred from other sources (X=10.3 vs. 5.9 weeks). While the majority (80.8%) had one admission to naltrexone treatment, 19.2% presented for readmission, some on three or more ocassions in the study period. The median period between the end of the first episode of treatment and commencement of the second was 15.6 weeks. The median period between the end of the second episode of treatment and commencement of the third was 11.4 weeks. Those employed had a higher probability of being retained longer in treatment than those who were unemployed in subsequent treatment episodes. Clinicians should respect that initial retention in naltrexone is likely to be relatively short, and that a substantial proportion of clients will represent for further treatment.

dc.publisherTaylor and Francis Ltd
dc.subjecttreatment retention
dc.subjectnaltrexone
dc.subjectdrug treatment centres
dc.subjectopioid-dependence
dc.titleCharacteristics, retention and readmissions of opioid-dependent clients treated with oral naltrexone
dc.typeJournal Article
dcterms.source.volume21
dcterms.source.number4
dcterms.source.startPage335
dcterms.source.endPage340
dcterms.source.issn09595236
dcterms.source.titleDrug and Alcohol Review
curtin.departmentSchool of Nursing and Midwifery
curtin.accessStatusFulltext not available
curtin.facultyFaculty of Health Sciences
curtin.facultyNational Drug Research Institute (Research Institute)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record